IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#581
Positioning
Market Dominance
Manufacturing
Medical Equipment
$16.6B
Stephen P. MacMillan
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company sells its products through direct sales and service forces, and independent distributors.
Headcount
6.9K
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = HOLX ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$UL UNILEVER PLC | 78 | 96 | 98 | 59 | - | - | 28.5% | 8.0% | 100.0% | 100.0% | 10.4% | -4.6% | 3.3% | 0.0x | $141.8B | VS | |
$ASML ASML HOLDING NV | 77 | 89 | 86 | 83 | - | - | 46.1% | 16.6% | 51.3% | 31.9% | 26.8% | -4.0% | 1.0% | 25.0x | $272.1B | VS | |
$ESLT ELBIT SYSTEMS LTD | 76 | 81 | 87 | 85 | - | - | 10.3% | 3.1% | 24.1% | 7.2% | 4.7% | 14.3% | 0.8% | 25.0x | $11.4B | VS | |
$MT ArcelorMittal | 75 | 71 | 98 | 85 | - | - | 2.2% | 1.5% | 9.3% | 5.3% | 2.2% | -8.5% | 2.2% | 16.0x | $18.9B | VS | |
$AMAT APPLIED MATERIALS INC /DE | 75 | 85 | 87 | 84 | 20.9x | 13.6x | 35.5% | 19.8% | 48.7% | 29.2% | 24.7% | 4.4% | 0.8% | 32.0x | $181.9B | VS | |
$SIMO Silicon Motion Technology CORP | 75 | 84 | 86 | 85 | - | - | 11.8% | 8.8% | 45.9% | 11.3% | 11.1% | 25.7% | 3.7% | 0.0x | $1.8B | VS | |
$CODA Coda Octopus Group, Inc. | 74 | 83 | 90 | 79 | 16.3x | 11.9x | 7.6% | 7.0% | 66.5% | 17.1% | 15.6% | 39.0% | 0.0% | 0.0x | $115M | VS | |
$GSK GSK plc | 74 | 84 | 90 | 70 | - | - | 22.6% | 4.9% | 71.2% | 12.8% | 9.4% | 1.7% | 5.9% | 124.0x | $72.1B | VS | |
$EFXT Enerflex Ltd. | 74 | 80 | 91 | 83 | - | - | 3.0% | 1.1% | 20.9% | 7.3% | 1.3% | 3.0% | 0.9% | 67.0x | $1.2B | VS | |
$BUD Anheuser-Busch InBev SA/NV | 74 | 84 | 97 | 63 | - | - | 8.2% | 3.5% | 55.3% | 25.9% | 12.4% | 0.7% | 1.7% | 0.0x | $87.0B | VS | |
$HOLX HOLOGIC INC | 61 | 61 | 70 | 53 | 31.4x | 21.7x | 10.2% | 5.8% | 51.4% | 17.4% | 12.9% | 3.6% | 0.0% | 48.0x | $16.6B | ||
| SECTOR BENCH | - | - | - | - | - | 22.3x | 11.5x | -2.5% | -0.1% | 42.5% | 1.3% | -0.2% | 5.9% | 0.0% | 0.2x | - | REF |
HOLOGIC INC (HOLX) receives a "Hold" rating with a composite score of 61.2/100. It ranks #581 out of 7,333 stocks in our coverage universe and carries a 3-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
Stephen P. MacMillan
Chief Executive Officer
Labor Force
6,940
61
44
95
Audit Verdict: Average governance indicators based on financial metrics.
No recent insider transactions available for HOLX
HQ Base
Wilmington, Massachusetts
In-line with peers — no strong momentum signal
Trading at a discount to fundamentals — favorable entry valuation
High profitability & efficiency — strong quality floor supports entry
Low volatility — smoother ride and historically better risk-adjusted returns
Moderate investment profile
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Manufacturing sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
Projection based on user-defined inputs. Re-calculated daily against current market data.
Reverse DCF Framework — Mauboussin Methodology
Institutional-grade Reverse DCF analysis. This model identifies the growth hurdles embedded in current market prices. When implied growth is significantly lower than historical or projected rates, a margin of safety may exist. Re-audited daily.
No analyst ratings for HOLX.
View All RatingsNet income exceeding cash flow (Accrual bloat detected)
Material decline in asset turnover efficiency detected
High margin volatility — erratic forensic earnings quality
| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 61 | 59 | +2NEUTRAL |
| MOMENTUM | 53 | 43 | +10ALPHA |
| VALUATION | 70 | 64 | +6ALPHA |
| INVESTMENT | 44 | 81 | -37DRAG |
| STABILITY | 95 | 98 | -3NEUTRAL |
| SHORT INT | 55 | 61 | -6DRAG |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROIC 51.5% vs WACC 8.6% (spread +42.9%)
GM 51% vs sector 43%, OM 17% vs sector 1%
Capital turnover 3.00x, R&D intensity 5.8%
Rev growth 4%, 11yr history
Interest coverage 8.6x, Net debt/EBITDA 1.1x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Our model assigns HOLOGIC INC a Hold rating, with a composite score of 61.2/100 and 3 out of 5 stars. Ranked #581 of 7,333 stocks, HOLX presents a mixed quantitative picture — neither compelling enough to initiate new positions nor weak enough to warrant selling. Investors already holding may consider maintaining their position while monitoring for changes in the factor profile.
With a quality score of 61/100, HOLX shows adequate but unremarkable business quality. The company reports a return on equity of 10.2% (sector avg: -2.5%), gross margins of 51.4% (sector avg: 42.5%), net margins of 12.9% (sector avg: -0.2%). This suggests the company generates acceptable returns but may lack the competitive positioning or operational efficiency to stand out from peers.
HOLX carries a solid value score of 70/100, pointing to an attractively priced stock relative to peers. Key valuation metrics include a P/E ratio of 31.43x, an EV/EBITDA of 21.71x, a P/B ratio of 3.21x. This score suggests reasonable compensation for the risks involved, with potential upside if the market recognizes the stock's underlying worth.
With an investment score of 44/100, HOLX exhibits moderate growth-oriented spending. Key growth metrics include revenue growth of 3.6% vs. a sector average of 5.9% and a return on assets of 5.8% (sector: -0.1%). The company appears to be balancing growth investments with capital returns, though the pace of investment may not be enough to accelerate top-line growth meaningfully.
HOLX demonstrates moderate momentum with a score of 53/100, suggesting a neutral price trend without strong directional conviction. Revenue growth stands at 3.6% year-over-year, while a beta of 0.32 reflects its sensitivity to broader market moves. Moderate momentum may indicate the stock is consolidating or transitioning between trends, warranting close monitoring of upcoming catalysts.
HOLOGIC INC earns an excellent stability score of 95/100, reflecting low price volatility and a conservatively managed balance sheet. Key stability metrics include a beta of 0.32 and a debt-to-equity ratio of 48.00x (sector avg: 0.2x). Stocks with this level of stability tend to act as portfolio anchors, providing downside protection during market corrections while still participating in broad market advances.
The short interest score of 55/100 for HOLX suggests somewhat elevated bearish positioning by institutional traders. Specific risk factors include elevated leverage (D/E: 48.00x). With a $16.6B market cap (large-cap), HOLOGIC INC may experience above-average volatility. Investors should consider whether the short thesis has merit or if it creates a potential short-squeeze opportunity.
HOLOGIC INC is a large-cap company in the Manufacturing sector, ranked #0 of 50 in its sector (100th percentile) and #581 of 7,333 overall (92nd percentile). Key comparisons include ROE of 10.2% exceeding the -2.5% sector median and operating margins of 17.4% above the 1.3% sector average. This top-quartile standing reflects exceptional competitive strength relative to Manufacturing peers.
While HOLX currently exhibits a HOLD profile, superior opportunities exist within the MANUFACTURING sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Manufacturing Alpha →Quant Factor Profile
Key factor gap
Stability (95) vs Investment (44) — closing this gap could shift the rating.
EV/EBITDA 89% ABOVE SECTOR MEDIAN
ROE 512% BELOW SECTOR MEDIAN
Gross Margin 21% ABOVE SECTOR MEDIAN (FAVORABLE)
AUDIT DATA AS OF DEC 27, 2025 (Q3 FY2025)
We rate HOLOGIC INC (HOLX) as a Hold with a composite score of 61.2/100 at a current price of $75.35. The stock presents a mixed quantitative picture — neither compelling enough to warrant new accumulation nor weak enough to justify selling for existing holders. Our factors are split, and the overall profile suggests patience is warranted.
The rating is primarily driven by strength in stability (95th percentile) and value (70th percentile), which together account for the majority of the composite score. All factors score above the 40th percentile, indicating no material weakness in the quantitative profile. We assign a Narrow Moat rating (67/100), Low uncertainty, and Standard capital allocation.
Key items to watch: quarterly earnings execution and sector-level competitive dynamics. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
HOLOGIC INC holds a top-quartile position (#0 of 50) within the Manufacturing sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 61.2/100 places it at rank #581 in our full 7,333-stock universe. With a $16.6B market capitalization, HOLOGIC INC operates at meaningful scale within the Manufacturing sector, providing competitive advantages in distribution, procurement, and customer reach.
Revenue is growing at 4%, though momentum at the 53th percentile suggests the market has not yet fully recognized this trajectory. This potential disconnect between fundamental improvement and market recognition could represent an opportunity for patient investors if the growth trend persists.
The margin cascade tells an important story: gross margins of 51% (+8.9pp vs sector) narrow to operating margins of 17% (+16.1pp vs sector) and net margins of 12.9%, yielding a gross-to-net conversion rate of 25%. This conversion rate is typical for the sector, suggesting a standard cost structure without notable efficiency advantages or disadvantages.
At a current price of $75.35, HOLOGIC INC appears undervalued relative to its fundamentals. Our value factor score of 70/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. The stock screens as attractively priced on a majority of these measures, suggesting the market may be underappreciating the underlying fundamentals.
The stock currently trades at a P/E of 31.4x (a 41% premium to the sector median of 22.3x), EV/EBITDA of 21.7x (at a premium), P/B of 3.2x, P/S of 4.1x. The above-sector P/E multiple suggests the market is pricing in superior growth or quality, which our analysis partially supports given strong quality metrics.
Gross margins of 51% signal strong pricing power and brand/IP advantages — businesses with margins above 40% have historically demonstrated more resilient earnings through economic cycles.
A value factor score of 70/100 suggests the market is underpricing these fundamentals, creating a potential margin of safety for new investors.
Even high-quality stocks face risks from valuation compression, competitive disruption, or macro shocks that are difficult to quantify in advance.
We assign a Low uncertainty rating to HOLOGIC INC. The company exhibits strong financial stability with a beta of 0.32, conservative leverage (48% D/E), and a stability factor in the 95th percentile. The predictable nature of the business model and solid financial position reduce the range of potential outcomes, giving us confidence in our fair value estimate.
Specific risk factors that inform our assessment include: low beta of 0.32 — while defensive, this may indicate limited upside participation in bull markets. Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 95th percentile and quality factor at the 61th percentile provide a quantitative summary of the overall risk landscape.
Key risk mitigants include: healthy gross margins of 51% provide a buffer against cost pressures; above-average stability (95th percentile) suggests predictable business dynamics. These factors partially offset the identified risks and provide downside protection in adverse scenarios. On balance, the risk-reward profile is favorable for long-term investors.
We rate HOLOGIC INC's capital allocation as Standard. Management has shown adequate — though not exceptional — stewardship of shareholder capital. Returns on equity stand at 10.2%, and the balance sheet is managed within acceptable parameters (D/E: 48%). Exemplary allocators typically sustain ROE above 20% and D/E below 50%; HOLOGIC INC falls short on at least one dimension.
There is room for improvement in optimizing the capital structure or enhancing shareholder returns. Absent a dividend, the overall capital allocation framework would benefit from either higher reinvestment returns, improved balance sheet efficiency, or increased shareholder distributions. We will monitor for signs of strategic improvement that could warrant an upgrade.
In summary, HOLOGIC INC receives a Hold rating with a composite score of 61.2/100 (rank #581 of 7,333). Our quantitative framework assigns a Narrow Moat (67/100, trend: stable), Low uncertainty, and Standard capital allocation. The average factor score across quality, value, momentum, stability, and investment is 65/100.
Our analysis supports a neutral stance on HOLOGIC INC. While the quantitative profile is not weak enough to warrant selling, it lacks the multi-factor strength required for a buy recommendation. Existing holders should maintain positions and monitor for catalysts — either fundamental improvement or valuation compression — that would shift the risk-reward balance.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We assign HOLOGIC INC a Narrow Moat rating with a composite moat score of 67/100. The ROIC-WACC spread of +42.9% is the primary signal of economic value creation. The company possesses identifiable competitive advantages, though they are less entrenched than those of wide-moat peers. Our analysis indicates that HOLOGIC INC can sustain above-average returns on invested capital for at least 10 years, with the strongest contributor being financial resilience at 17.2/20.
The strongest moat sources are financial resilience (17.2/20) and margin superiority (16.6/20). Interest coverage 8.6x, Net debt/EBITDA 1.1x. GM 51% vs sector 43%, OM 17% vs sector 1%. These pillars form the core of HOLOGIC INC's competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include reinvestment efficiency (8/20) and growth durability (10.4/20). Capital turnover 3.00x, R&D intensity 5.8%. Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect HOLOGIC INC's moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include gross margins of 51% providing a solid profitability foundation, operating margins of 17% reflecting effective cost management. The margin cascade from 51% gross to 17% operating to 12.9% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that the profit engine is high-quality and likely sustainable, with the quality factor at the 61th percentile.
The margin profile shows gross margins of 51%, operating margins of 17%, net margins of 12.9%. Return metrics include ROE of 10.2% and ROA of 5.8%. Relative to the Manufacturing sector, gross margins are 8.9 percentage points above the sector median of 43%, and ROE of 10.2% compares to a sector median of -2.5%.
The balance sheet reflects moderate leverage with D/E of 48%, revenue growth of 4%. The sector median D/E is 0%, putting HOLOGIC INC at higher leverage than the typical peer. The combination of low leverage and healthy profitability provides significant financial resilience and strategic optionality.
Above 50MA
37.18%
Net New Highs
+51081
Bloomberg reports that Johnson & Johnson (NYSE: JNJ) aims to sell its DePuy Synthes Orthopaedics business for more than $20 billion.
Blackstone (NYSE:BX) has signed a definitive deal to acquire Champions Group, a major home services provider. The transaction will see Odyssey Investment Partners retain a significant minority stake in Champions Group. The deal extends Blackstone's exposure to essential service businesses that are viewed as less affected by rapid technology shifts. For you as an investor looking at NYSE:BX, this move increases the focus on businesses that provide day-to-day services to households, an area...

AI-driven clinical intelligence is transforming medical imaging, with point-of-care diagnostics projected to reach $70.92 billion by 2032. The CMS ACCESS Model launching in July 2026 will reward outcome-based care, driving adoption of software-defined imaging platforms. Key players including VentriPoint Diagnostics, Butterfly Network, Hyperfine, Hologic, and GE HealthCare are advancing portable, AI-powered diagnostic solutions that deliver hospital-grade precision at the bedside, reducing facility overhead while improving patient outcomes.
Pulse BioSciences’ CTO knows what it takes to create successful medtech and sometimes, it takes partnering with the competition.